Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human NRSN2 ELISA Kit (AC3670)
Cat.#: ASET-2259
Specifications
Description Human NRSN2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human NRSN2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.54 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1380 Rat FGF2 ELISA Kit (AC2791) Quantitative inquiry ASET-1834 Mouse P2Y1 ELISA Kit (AC3245) Quantitative inquiry ASET-1522 Human P Cadherin ELISA Kit (AC2933) Quantitative inquiry ASET-1857 Human DLL1 ELISA Kit (AC3268) Quantitative inquiry ASET-2449 Human TPH2 ELISA Kit (AC3860) Quantitative inquiry ASET-2343 Goat C Peptide ELISA Kit (AC3754) Quantitative inquiry ASET-2116 Mouse NG2 ELISA Kit (AC3527) Quantitative inquiry ASET-2458 Human Meteorin ELISA Kit (AC3869) Quantitative inquiry ASET-2285 Human HEXA ELISA Kit (AC3696) Quantitative inquiry ASET-1331 Rat Glutamate Receptor 1 (AMPA subtype) ELISA Kit (AC2742) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket